# SOX10

## Overview
The SOX10 gene encodes the SRY-box transcription factor 10, a critical protein involved in the regulation of gene expression during the development and differentiation of neural crest-derived cells. This transcription factor is characterized by its high mobility group (HMG) domain, which facilitates DNA binding and is essential for its function in cellular processes. SOX10 plays a pivotal role in the development of the peripheral and central nervous systems, particularly in the differentiation of Schwann cells and oligodendrocytes, as well as in melanocyte development and pigmentation. The protein's interactions with other transcription factors, such as PAX3 and EGR2, underscore its importance in synergistic gene regulation and chromatin remodeling. Mutations in the SOX10 gene are linked to several genetic disorders, including Waardenburg syndrome and Hirschsprung disease, and have implications in various cancers, highlighting its clinical significance (Pingault2021SOX10:; Bahmad2023Clinical).

## Structure
The SOX10 protein is a transcription factor characterized by a highly conserved high mobility group (HMG) domain, which is crucial for its DNA-binding activity. This domain consists of 80 amino acids and is composed of three α-helices that form an L-type shape, with a hydrophobic core at the intersection to maintain structural integrity (Chaoui2011Identification). The HMG domain allows SOX10 to bind to the DNA minor groove and recognize a 7 bp consensus DNA element (Chaoui2011Identification). 

SOX10 also contains a DNA-dependent dimerization domain located between amino acids 61-101, which is necessary for cooperative binding to target gene promoters (Schreiner2007Hypomorphic). The protein has a transactivation domain at the C-terminus (amino acids 400-466) and a K2 domain (amino acids 233-306) with transactivation potential (Schreiner2007Hypomorphic). 

The protein undergoes nucleocytoplasmic shuttling, facilitated by nuclear localization signals (NLSs) and a nuclear export signal (NES) (Chaoui2011Identification). Mutations in the HMG domain can lead to altered protein configurations, affecting its activity and leading to disease (Chaoui2011Identification). The SOX10 protein's structure and function are further influenced by its ability to bind DNA both as a monomer and a dimer, with different functional consequences (Peirano2000The).

## Function
The SOX10 gene encodes a transcription factor that plays a crucial role in the development and differentiation of neural crest-derived cells, including melanocytes and glial cells. In healthy human cells, SOX10 is involved in the regulation of gene expression by binding to specific DNA sequences, influencing the transcription of target genes essential for cell differentiation and survival (Mollaaghababa2003The; Bahmad2023Clinical). 

SOX10 is particularly important in the peripheral nervous system, where it regulates the differentiation of Schwann cells and glial cells by controlling the expression of myelin genes such as protein zero (P0) (Bahmad2023Clinical). In the central nervous system, SOX10 is expressed in oligodendrocytes, where it is crucial for their differentiation into myelinating cells (Mollaaghababa2003The). 

In melanocytes, SOX10 regulates the expression of the Microphthalmia-associated transcription factor (MITF), which is vital for melanocyte differentiation and pigment production (Mollaaghababa2003The). SOX10 also interacts with other transcription factors, such as PAX3, to activate MITF expression, highlighting its role in synergistic gene regulation (Mollaaghababa2003The). 

Overall, SOX10 is essential for the proper development and function of several cell types derived from neural crest cells, impacting processes like cell differentiation, survival, and pigmentation (Bahmad2023Clinical).

## Clinical Significance
Mutations in the SOX10 gene are associated with several genetic disorders, primarily Waardenburg syndrome (WS) and Hirschsprung disease (HD). Waardenburg syndrome is characterized by sensorineural hearing loss and pigmentation anomalies, with SOX10 mutations particularly linked to types 2 and 4 (WS2 and WS4). WS4, also known as Waardenburg-Hirschsprung disease, includes symptoms such as pigmentation defects, deafness, and HD, a condition marked by aganglionic segments in the intestine (Pingault2010Review; Bondurand2007Deletions). SOX10 mutations can also lead to a more severe phenotype known as PCWH syndrome, which includes peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, WS, and HD (Moldenæs2021Clinical).

SOX10 mutations are implicated in Kallmann syndrome (KS), characterized by hypogonadotropic hypogonadism and anosmia, often accompanied by hearing impairment (Pingault2021SOX10:; Bahmad2023Clinical). Alterations in SOX10 expression are linked to various cancers, acting as both a tumor suppressor and promoter in different cancer types, including melanoma and urothelial carcinoma (Bahmad2023Clinical). The gene's role in neural crest development and its regulatory influence on other genes contribute to the diverse phenotypic outcomes observed in these conditions (Pingault2021SOX10:).

## Interactions
SOX10 is a transcription factor that engages in various interactions with other proteins and nucleic acids, playing a crucial role in gene regulation. It interacts with PAX3 to regulate the expression of the RET proto-oncogene, essential for neural crest development. This interaction involves a composite PAX3/SOX10 binding sequence on the c-RET promoter, although SOX10's DNA binding is not necessary for their cooperativity (Bernard2010Acquisition). SOX10 also synergistically activates the MITF promoter with PAX3, requiring SOX10's DNA binding activity (Bondurand2000Interaction).

In Schwann cell fate specification, SOX10 interacts with EGR2 and NMI to regulate the Myelin protein zero (MPZ) gene. The interaction with EGR2 likely involves a composite DNA element, while NMI lacks DNA binding activity, indicating a promoter-specific synergy (Bernard2010Acquisition). SOX10 also forms a ternary complex with AP2a on the U3 enhancer, crucial for neural crest-specific gene regulation, and recruits FoxD3 to the enhancer, facilitating cooperative binding (Wahlbuhl2011Transcription).

In melanocyte development, SOX10's activity is modulated by Sox5, which recruits transcriptional corepressors like HDAC1 and CtBP2 to melanocyte-specific promoters, influencing gene expression (Stolt2008The). These interactions underscore SOX10's role in chromatin remodeling and transcriptional regulation.


## References


[1. (Bondurand2007Deletions) Nadege Bondurand, Florence Dastot-Le Moal, Laure Stanchina, Nathalie Collot, Viviane Baral, Sandrine Marlin, Tania Attie-Bitach, Irina Giurgea, Laurent Skopinski, William Reardon, Annick Toutain, Pierre Sarda, Anis Echaieb, Marilyn Lackmy-Port-Lis, Renaud Touraine, Jeanne Amiel, Michel Goossens, and Veronique Pingault. Deletions at the sox10 gene locus cause waardenburg syndrome types 2 and 4. The American Journal of Human Genetics, 81(6):1169–1185, December 2007. URL: http://dx.doi.org/10.1086/522090, doi:10.1086/522090. This article has 200 citations.](https://doi.org/10.1086/522090)

[2. (Bahmad2023Clinical) Hisham F. Bahmad, Aran Thiravialingam, Karthik Sriganeshan, Jeffrey Gonzalez, Veronica Alvarez, Stephanie Ocejo, Alvaro R. Abreu, Rima Avellan, Alejandro H. Arzola, Sana Hachem, and Robert Poppiti. Clinical significance of sox10 expression in human pathology. Current Issues in Molecular Biology, 45(12):10131–10158, December 2023. URL: http://dx.doi.org/10.3390/cimb45120633, doi:10.3390/cimb45120633. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cimb45120633)

[3. (Stolt2008The) C. C. Stolt, P. Lommes, S. Hillgartner, and M. Wegner. The transcription factor sox5 modulates sox10 function during melanocyte development. Nucleic Acids Research, 36(17):5427–5440, August 2008. URL: http://dx.doi.org/10.1093/nar/gkn527, doi:10.1093/nar/gkn527. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkn527)

[4. (Schreiner2007Hypomorphic) Silke Schreiner, François Cossais, Kerstin Fischer, Stefanie Scholz, Michael R. Bösl, Bettina Holtmann, Michael Sendtner, and Michael Wegner. Hypomorphic sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages. Development, 134(18):3271–3281, September 2007. URL: http://dx.doi.org/10.1242/dev.003350, doi:10.1242/dev.003350. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.003350)

[5. (Pingault2010Review) Véronique Pingault, Dorothée Ente, Florence Dastot-Le Moal, Michel Goossens, Sandrine Marlin, and Nadège Bondurand. Review and update of mutations causing waardenburg syndrome. Human Mutation, 31(4):391–406, February 2010. URL: http://dx.doi.org/10.1002/humu.21211, doi:10.1002/humu.21211. This article has 445 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21211)

[6. (Pingault2021SOX10:) Veronique Pingault, Lisa Zerad, William Bertani-Torres, and Nadege Bondurand. Sox10: 20 years of phenotypic plurality and current understanding of its developmental function. Journal of Medical Genetics, 59(2):105–114, October 2021. URL: http://dx.doi.org/10.1136/jmedgenet-2021-108105, doi:10.1136/jmedgenet-2021-108105. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2021-108105)

[7. (Bernard2010Acquisition) Pascal Bernard and Vincent R. Harley. Acquisition of sox transcription factor specificity through protein–protein interaction, modulation of wnt signalling and post-translational modification. The International Journal of Biochemistry &amp; Cell Biology, 42(3):400–410, March 2010. URL: http://dx.doi.org/10.1016/j.biocel.2009.10.017, doi:10.1016/j.biocel.2009.10.017. This article has 72 citations.](https://doi.org/10.1016/j.biocel.2009.10.017)

[8. (Peirano2000The) R. I. Peirano. The glial transcription factor sox10 binds to dna both as monomer and dimer with different functional consequences. Nucleic Acids Research, 28(16):3047–3055, August 2000. URL: http://dx.doi.org/10.1093/nar/28.16.3047, doi:10.1093/nar/28.16.3047. This article has 229 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/28.16.3047)

[9. (Bondurand2000Interaction) N. Bondurand. Interaction among sox10, pax3 and mitf, three genes altered in waardenburg syndrome. Human Molecular Genetics, 9(13):1907–1917, August 2000. URL: http://dx.doi.org/10.1093/hmg/9.13.1907, doi:10.1093/hmg/9.13.1907. This article has 362 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/9.13.1907)

[10. (Moldenæs2021Clinical) Marika F. Moldenæs, Nanna D. Rendtorff, Lone S. Hindbæk, Pernille M. Tørring, Øivind Nilssen, and Lisbeth Tranebjærg. Clinical manifestations and novel pathogenic variants in sox10 in eight danish probands with waardenburg syndrome. European Journal of Medical Genetics, 64(9):104265, September 2021. URL: http://dx.doi.org/10.1016/j.ejmg.2021.104265, doi:10.1016/j.ejmg.2021.104265. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2021.104265)

[11. (Wahlbuhl2011Transcription) M. Wahlbuhl, S. Reiprich, M. R. Vogl, M. R. Bosl, and M. Wegner. Transcription factor sox10 orchestrates activity of a neural crest-specific enhancer in the vicinity of its gene. Nucleic Acids Research, 40(1):88–101, September 2011. URL: http://dx.doi.org/10.1093/nar/gkr734, doi:10.1093/nar/gkr734. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkr734)

[12. (Chaoui2011Identification) Asma Chaoui, Yuli Watanabe, Renaud Touraine, Viviane Baral, Michel Goossens, Veronique Pingault, and Nadege Bondurand. Identification and functional analysis ofsox10missense mutations in different subtypes of waardenburg syndrome. Human Mutation, 32(12):1436–1449, September 2011. URL: http://dx.doi.org/10.1002/humu.21583, doi:10.1002/humu.21583. This article has 70 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21583)

[13. (Mollaaghababa2003The) Ramin Mollaaghababa and William J Pavan. The importance of having your sox on: role of sox10† in the development of neural crest-derived melanocytes and glia. Oncogene, 22(20):3024–3034, May 2003. URL: http://dx.doi.org/10.1038/sj.onc.1206442, doi:10.1038/sj.onc.1206442. This article has 177 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1206442)